GHAPPcast

Thank you to Ardelyx for sponsoring this FAQ Video Module! 

Join Kim Orleck, GHAPP member and Physician Assistant at Atlanta Gastroenterology Associates. In this FAQ, Kim discusses how new mechanisms of action influence her prescribing decisions for IBS-C therapy. She highlights the exciting introduction of a novel medication with a triple-action mechanism of action, which offers an alternative to the traditional secretago...

In this episode of GHAPPcast, host Gabriella McCarty, a Nurse Practitioner, is joined by fellow Nurse Practitioner Tedra Gray. They delve into the world of biosimilars, focusing on empowering Advanced Practice Providers (APPs) for better patient conversations.

Listen in as they discuss the role of APPs in patient education, strategies for overcoming challenges with biosimilars, and how to effectively communicate the benefi...

Join Dr. Nadege Gunn, from the 2024 Liver Connect Conference. In this special episode, she is joined by Elizabeth Coacher, PA, and Ann Moore, FNP, to discuss the management of NASH (Nonalcoholic Steatohepatitis), newly approved treatments, and the importance of clinical trials.

They explore patient-centered care, lifestyle modifications, and non-invasive tests for identifying at-risk patients. Tune in for insights on balancing clini...

In our twelfth and final episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP, and guest Jamie Brogan, NP have an in-depth conversation about discussing biosimilars with patients.

The learning objectives for this episode are to:

• Design methods to appropriately explain biosimilars to patients
• Address potential patient perceptions of biosimilars
• Devise methods to combat the nocebo effect whe...

Welcome to our eleventh episode of the GHAPP & RhAPP biosimilar podcast series! In the penultimate episode host Amanda Mixon, PA-C has an in-depth conversation with the incredible Naomi A. Amudala, CRNP, MSN,  about The Nocebo Effect.

The learning objectives and goals for this episode are to:

• Define the nocebo effect
• Appraise nocebo effect research as it pertains to biosimilars
• Explain effective ways to counter the no...

In the tenth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP-C, and guest Sharon Dudley-Brown PHD, FNP-BC, FAAN, FAANP discuss the practical use of biosimilars in Gastroenterology APP practice.

The learning objectives for this episode are to:

• Interpret the AGA Biosimilars Roundtable meeting report and the Crohn’s & Colitis Foundation Biosimilar position statement
• Discuss the use ...

In the ninth episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Daric Mueller, PA-C discuss the practical use of biosimilars in rheumatology APP practice.

The learning objectives for this episode are to:

• Interpret the ACR white paper on biosimilars in rheumatology
• Discuss the use of biosimilars in the treatment of rheumatic diseases
• Produce strategies for implementing the use of ...

In our eighth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP, and guest Gwen Cassidy, NP review the benefits of biosimilars.

The learning objectives for this episode are to:

• Outline the cost savings of biosimilars for patients
• Summarize the cost savings for healthcare organizations
• Discuss  healthcare providers  feeling the pressure and burden of rising costs and how biosimilars may ...

In the seventh episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Audrey Gibson, PA-C discuss the interplay between managed care and biosimilars.

The learning objectives for this episode are to:

• Discuss managed care implications for biosimilars reaching the market
• Identify the benefits of biosimilars in managed care
• Formulate strategies managed care professionals can employ to es...

For our sixth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP-C, and guest Janette Villalon, NP discuss interchangeability & switching of biosimilars.

The learning objectives and goals for this episode are to:
-Define interchangeability
-Illustrate the required info for a biosimilar to be deemed interchangeable by the FDA
-Recognize how interchangeability studies are co...

In the fifth episode of the GHAPP & RhAPP biosimilar podcast series host Amanda Mixon, PA-C, and guest Betsy Kirchner, DNP review the important concept of biosimilar extrapolation.

The learning objectives for this episode are to:

• Define extrapolation
• Understand why extrapolation is important.
• Understand the key aspects that may be considered for scientific justification of extrapolation including:
         -MOA in e...

In the fourth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP  and guest Tedra Gray, NP discuss the differences between biosimilars and generic drugs.

The learning objectives and goals for this episode are to:
-Compare and contrast biosimilars and generics regarding:
         -Molecular size and structure
         -Complexity of development
         -Cost of development...

Welcome to our third episode of the GHAPP & RhAPP biosimilar podcast series! In this episode host Amanda Mixon, PA-C has an in-depth conversation with the incredible Danielle Gatti-Palumbo, PharmD, BCACP, AAHIVP,  about The Regulatory Pathway to Biosimilar Approval.

The learning objectives and goals for this episode are to:
-Summarize the totality of evidence approach to determining biosimilarity including:
   ...

Join us for our second episode of the GHAPP & RhAPP biosimilar podcast series! In this episode host Amanda Mixon, PA-C discusses the Development of Biosimilars with our esteemed guest Tanya Golovanoff, PharmD.

The learning objectives and goals for this episode are to:
-Distill the immense amount of research and development that occurs to develop biosimilars
-Articulate the biosimilar manufacturing process
...

Join us for the first episode of the GHAPP & RhAPP biosimilar podcast series! In this episode Gabriella McCarty, NP-C and Jennifer Geremia, PA-C discuss What Are Biosimilars?

The learning objectives and goals for this episode are to:
-Define biologic therapy
-Define biosimilars
-Define reference product
-Summarize the impact of The Biologics Price Competition and Innovation Act

Please take our...